Long-term Safety Follow-up of Subjects With Giant Cell Tumor of Bone Treated With Denosumab in Study 20062004
Clinical trial NCT03301857 · COMPLETED
Trial details
- NCT number
- NCT03301857
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-13
- Primary completion
- 2023-07-27
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.